Further, the inflammatory cytokine pentraxin 3 (PTX3) has been observed to change in poorly‐differentiated clinical breast cancer samples[104] and the S100 calcium binding family member S100A4 has been implicated in endometrial cancer progression through EMT.[105]. This evidence concerns the gene PTX3 and breast carcinoma.